Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants
Purpose: Integration of evidence-based innovations, such as serum neurofilament light chain (sNfL) measurement into routine practice represents a pivotal opportunity to advance personalized care in multiple sclerosis (MS) management. This study assessed neurologists' openness to adopting healthcare...
| Authors: | ; ; ; ; ; ; ; ; ; ; ; ; |
|---|---|
| Format: | Article |
| Status: | Published version |
| Publication date: | 2025 |
| Country: | España |
| Institution: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repository: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/222834 |
| Online Access: | https://hdl.handle.net/2445/222834 |
| Access Level: | Open access |
| Keyword: | Esclerosi múltiple Medicina basada en l'evidència Multiple sclerosis Evidence-based medicine |
| _version_ | 1878739140847075328 |
|---|---|
| author | Monreal, Enric |
| author2 | Gómez Ballesteros, Rocío Meca Lallana, Virginia Caminero, Ana Meca Lallana, José E. Martínez Yélamos, Sergio Landete, Lamberto García Domínguez, José M. Agüera, Eduardo García Arcelay, Elena Medrano, Nicolas Villar, Luisa M. Maurino, Jorge |
| author2_role | author author author author author author author author author author author author |
| author_browse | Agüera, Eduardo Caminero, Ana García Arcelay, Elena García Domínguez, José M. Gómez Ballesteros, Rocío Landete, Lamberto Martínez Yélamos, Sergio Maurino, Jorge Meca Lallana, José E. Meca Lallana, Virginia Medrano, Nicolas Monreal, Enric Villar, Luisa M. |
| author_facet | Monreal, Enric Gómez Ballesteros, Rocío Meca Lallana, Virginia Caminero, Ana Meca Lallana, José E. Martínez Yélamos, Sergio Landete, Lamberto García Domínguez, José M. Agüera, Eduardo García Arcelay, Elena Medrano, Nicolas Villar, Luisa M. Maurino, Jorge |
| author_role | author |
| collection | Recercat. Dipósit de la Recerca de Catalunya |
| description | Purpose: Integration of evidence-based innovations, such as serum neurofilament light chain (sNfL) measurement into routine practice represents a pivotal opportunity to advance personalized care in multiple sclerosis (MS) management. This study assessed neurologists' openness to adopting healthcare innovations (sNfL testing), focusing on individual characteristics and structural factors like workplace environment and resources. Methods: An observational, cross-sectional study was conducted in partnership with the Spanish Society of Neurology. Neurologists caring for patients with MS completed an e-survey assessing openness to innovation using the Openness subscale of the EvidenceBased Practice Attitude Scale (EBPAS), alongside measures of empathy, healthcare-related regret, risk preferences, burnout, and workplace communication. Logistic and linear regression models were conducted to identify predictors of openness to innovation. Results: One hundred and sixteen neurologists were studied. Mean age (SD) was 41.9 (10.1) years, 53.4% were male. Mean experience as neurologists was 16.0 (9.2) years and 96.6% worked in an academic hospital. Median (IQR) EBPAS-Openness score was 3.0 (2.5-3.5), with 54.3% (n=63) of participants demonstrating openness to innovation. Participants fully dedicated to MS care, managing higher patient volumes, engaged in research publications, with access to serum neurofilament light chain testing, and a greater propensity for risk-taking, were more open to adopting innovations than their counterparts. Multivariate logistic regression analysis showed that access to sNfL testing and higher empathy levels were significant predictors of openness (OR=3.52, CI 95%: 1.3-10.3; p=0.016 and OR=1.09, CI 95%: 1.0-1.2; p=0.005, respectively). Complementary linear regression reinforced the significant positive association between higher EBPAS-Openness scores and empathy (estimate=0.024, p=0.001). Conclusion: Neurologists exhibited a varied openness to innovation. Implementing initial innovative strategies in clinical practice should prioritize neurologists with specific profiles to support the integration of emerging tools and personalized healthcare approaches in MS care. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | ES_bbdac5a2b20e5f05ef7a6e01780dfd79 |
| institution | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| instname_str | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| network_acronym_str | ES |
| network_name_str | España |
| oai_identifier_str | oai:recercat.cat:2445/222834 |
| publishDate | 2025 |
| publishDateSort | 2025 |
| publisher | Informa UK Limited |
| publisherStr | Informa UK Limited |
| reponame_str | Recercat. Dipósit de la Recerca de Catalunya |
| spelling | Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants Monreal, Enric Gómez Ballesteros, Rocío Meca Lallana, Virginia Caminero, Ana Meca Lallana, José E. Martínez Yélamos, Sergio Landete, Lamberto García Domínguez, José M. Agüera, Eduardo García Arcelay, Elena Medrano, Nicolas Villar, Luisa M. Maurino, Jorge Esclerosi múltiple Medicina basada en l'evidència Multiple sclerosis Evidence-based medicine Purpose: Integration of evidence-based innovations, such as serum neurofilament light chain (sNfL) measurement into routine practice represents a pivotal opportunity to advance personalized care in multiple sclerosis (MS) management. This study assessed neurologists' openness to adopting healthcare innovations (sNfL testing), focusing on individual characteristics and structural factors like workplace environment and resources. Methods: An observational, cross-sectional study was conducted in partnership with the Spanish Society of Neurology. Neurologists caring for patients with MS completed an e-survey assessing openness to innovation using the Openness subscale of the EvidenceBased Practice Attitude Scale (EBPAS), alongside measures of empathy, healthcare-related regret, risk preferences, burnout, and workplace communication. Logistic and linear regression models were conducted to identify predictors of openness to innovation. Results: One hundred and sixteen neurologists were studied. Mean age (SD) was 41.9 (10.1) years, 53.4% were male. Mean experience as neurologists was 16.0 (9.2) years and 96.6% worked in an academic hospital. Median (IQR) EBPAS-Openness score was 3.0 (2.5-3.5), with 54.3% (n=63) of participants demonstrating openness to innovation. Participants fully dedicated to MS care, managing higher patient volumes, engaged in research publications, with access to serum neurofilament light chain testing, and a greater propensity for risk-taking, were more open to adopting innovations than their counterparts. Multivariate logistic regression analysis showed that access to sNfL testing and higher empathy levels were significant predictors of openness (OR=3.52, CI 95%: 1.3-10.3; p=0.016 and OR=1.09, CI 95%: 1.0-1.2; p=0.005, respectively). Complementary linear regression reinforced the significant positive association between higher EBPAS-Openness scores and empathy (estimate=0.024, p=0.001). Conclusion: Neurologists exhibited a varied openness to innovation. Implementing initial innovative strategies in clinical practice should prioritize neurologists with specific profiles to support the integration of emerging tools and personalized healthcare approaches in MS care. Informa UK Limited https://hdl.handle.net/2445/222834 |
| spellingShingle | Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants Monreal, Enric Esclerosi múltiple Medicina basada en l'evidència Multiple sclerosis Evidence-based medicine |
| status_str | publishedVersion |
| title | Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants |
| title_full | Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants |
| title_fullStr | Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants |
| title_full_unstemmed | Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants |
| title_short | Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants |
| title_sort | Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants |
| topic | Esclerosi múltiple Medicina basada en l'evidència Multiple sclerosis Evidence-based medicine |
| topic_facet | Esclerosi múltiple Medicina basada en l'evidència Multiple sclerosis Evidence-based medicine |
| url | https://hdl.handle.net/2445/222834 |